Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2777 USD | -0.89% | +8.39% | -42.51% |
04-22 | Avalon GloboCare Corp. Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference | CI |
04-17 | North American Morning Briefing : Stock Futures -2- | DJ |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 200.9 | 146.2 | 91.17 | 72.49 | 51.72 | 5.313 |
Enterprise Value (EV) 1 | 199.6 | 148.7 | 94.17 | 74.98 | 54.31 | 13.53 |
P/E ratio | -25.5 x | -8.02 x | -7.02 x | -7.66 x | -4.07 x | -0.3 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 133 x | 98.1 x | 68.7 x | 54.5 x | 44.6 x | -0.72 x |
EV / Revenue | 132 x | 99.7 x | 71 x | 56.4 x | 46.8 x | -1.85 x |
EV / EBITDA | -27.9 x | -8.3 x | -7.72 x | -8.74 x | -7.59 x | -0.87 x |
EV / FCF | -37.9 x | 362 x | -44.4 x | -42.9 x | -29.4 x | -1.76 x |
FCF Yield | -2.64% | 0.28% | -2.25% | -2.33% | -3.4% | -56.8% |
Price to Book | 16.6 x | 32.9 x | 22.4 x | 23.5 x | 24 x | -0.42 x |
Nbr of stocks (in thousands) | 7,304 | 7,577 | 8,140 | 8,840 | 9,946 | 11,000 |
Reference price 2 | 27.50 | 19.30 | 11.20 | 8.200 | 5.200 | 0.4830 |
Announcement Date | 19-03-26 | 20-04-06 | 21-03-30 | 22-03-30 | 23-03-30 | 24-04-15 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 1.509 | 1.491 | 1.326 | 1.331 | 1.16 | -7.334 |
EBITDA 1 | -7.161 | -17.92 | -12.19 | -8.583 | -7.154 | -15.56 |
EBIT 1 | -7.684 | -18.42 | -12.51 | -8.894 | -7.485 | -15.77 |
Operating Margin | -509.11% | -1,236% | -943.05% | -668.49% | -645.07% | 215.05% |
Earnings before Tax (EBT) 1 | -8.052 | -18.07 | -12.68 | -9.09 | -11.93 | -16.71 |
Net income 1 | -7.774 | -18.07 | -12.68 | -9.09 | -11.93 | -16.71 |
Net margin | -515.08% | -1,212.33% | -956.15% | -683.23% | -1,028.25% | 227.8% |
EPS 2 | -1.080 | -2.406 | -1.595 | -1.071 | -1.279 | -1.587 |
Free Cash Flow 1 | -5.267 | 0.4104 | -2.122 | -1.747 | -1.844 | -7.691 |
FCF margin | -348.97% | 27.53% | -160.02% | -131.29% | -158.95% | 104.87% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 19-03-26 | 20-04-06 | 21-03-30 | 22-03-30 | 23-03-30 | 24-04-15 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 2.43 | 3.01 | 2.49 | 2.58 | 8.22 |
Net Cash position 1 | 1.25 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | -0.1354 x | -0.2466 x | -0.2901 x | -0.3611 x | -0.5283 x |
Free Cash Flow 1 | -5.27 | 0.41 | -2.12 | -1.75 | -1.84 | -7.69 |
ROE (net income / shareholders' equity) | -86.8% | -230% | -295% | -252% | -168% | -180% |
ROA (Net income/ Total Assets) | -36.9% | -96.4% | -74.9% | -53.9% | -31.2% | -48.9% |
Assets 1 | 21.1 | 18.74 | 16.92 | 16.85 | 38.25 | 34.18 |
Book Value Per Share 2 | 1.650 | 0.5900 | 0.5000 | 0.3500 | 0.2200 | -1.150 |
Cash Flow per Share 2 | 0.3100 | 0.1000 | 0.0900 | 0.0900 | 0.2000 | 0.0300 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 19-03-26 | 20-04-06 | 21-03-30 | 22-03-30 | 23-03-30 | 24-04-15 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-42.51% | 3.11M | |
-16.99% | 8.39B | |
+54.07% | 3.74B | |
-37.54% | 2.55B | |
-9.63% | 2.48B | |
-13.43% | 2.32B | |
-4.20% | 1.93B | |
-18.24% | 1.6B | |
-36.41% | 1.28B | |
+2.19% | 1.08B |
- Stock Market
- Equities
- ALBT Stock
- Financials Avalon GloboCare Corp.